At Lexogen NGS Services, the proprietary technologies are fully integrated into customizable, end-to-end Blood RNA-Seq Service workflows, available with RNA extraction from blood collection tubes and ...

Reprioritized resources to reduce costs and enhance focus on Nana-val's development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data ...

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology ...

This important manuscript provides insights into the competition between Splicing Factor 1 (SF1) and Quaking (QKI) for binding at the ACUAA branch point sequence in a model intron, regulating exon ...

For more information on Quantum-Si's technology and research applications, please visit The Protein Sequencing Company™ | Quantum-Si ...

The restructuring is aimed at freeing up resources so the firm can advance its EBV-positive peripheral T-cell lymphoma drug toward the market.

This valuable study reveals extensive binding of eukaryotic translation initiation factor 3 (eIF3) to the 3' untranslated regions (UTRs) of efficiently translated mRNAs in human pluripotent stem ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

The SITC posters will be available on ImCheck's corporate website after the poster sessions have been opened.

Placenta’s Unexpected Influence on Maternal Mental Health: Study FindsProfessor Clifton's team at the Mater Research ...

Oxford Nanopore Technologies observes that direct analysis has already enhanced research across species, disease states, and applications.

AMSBIO has launched the iMatrix Palette, a comprehensive kit designed to streamline cell culture and differentiation ...